15-64854934-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_025201.5(PLEKHO2):c.176G>A(p.Cys59Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.0000595 in 1,613,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000063 ( 0 hom. )
Consequence
PLEKHO2
NM_025201.5 missense
NM_025201.5 missense
Scores
4
12
3
Clinical Significance
Conservation
PhyloP100: 6.51
Genes affected
PLEKHO2 (HGNC:30026): (pleckstrin homology domain containing O2) Predicted to act upstream of or within macrophage apoptotic process. Predicted to be located in extracellular region and ficolin-1-rich granule lumen. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.749
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLEKHO2 | NM_025201.5 | c.176G>A | p.Cys59Tyr | missense_variant | 3/6 | ENST00000323544.5 | NP_079477.2 | |
PLEKHO2 | NM_001195059.2 | c.26G>A | p.Cys9Tyr | missense_variant | 2/5 | NP_001181988.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLEKHO2 | ENST00000323544.5 | c.176G>A | p.Cys59Tyr | missense_variant | 3/6 | 1 | NM_025201.5 | ENSP00000326706.4 | ||
PLEKHO2 | ENST00000616065.4 | c.26G>A | p.Cys9Tyr | missense_variant | 2/5 | 1 | ENSP00000483505.1 | |||
ENSG00000249240 | ENST00000437723.1 | c.176G>A | p.Cys59Tyr | missense_variant | 3/7 | 5 | ENSP00000397942.1 | |||
ENSG00000249240 | ENST00000502574.1 | n.310G>A | non_coding_transcript_exon_variant | 3/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152232Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
4
AN:
152232
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000481 AC: 12AN: 249536Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134738
GnomAD3 exomes
AF:
AC:
12
AN:
249536
Hom.:
AF XY:
AC XY:
5
AN XY:
134738
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000630 AC: 92AN: 1460804Hom.: 0 Cov.: 31 AF XY: 0.0000523 AC XY: 38AN XY: 726506
GnomAD4 exome
AF:
AC:
92
AN:
1460804
Hom.:
Cov.:
31
AF XY:
AC XY:
38
AN XY:
726506
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74380
GnomAD4 genome
AF:
AC:
4
AN:
152232
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.176G>A (p.C59Y) alteration is located in exon 3 (coding exon 3) of the PLEKHO2 gene. This alteration results from a G to A substitution at nucleotide position 176, causing the cysteine (C) at amino acid position 59 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;L;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
.;D;D
REVEL
Uncertain
Sift
Uncertain
.;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;D;.
Vest4
MutPred
0.43
.;Loss of methylation at K58 (P = 0.0199);Loss of methylation at K58 (P = 0.0199);
MVP
MPC
0.65
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at